XML 33 R20.htm IDEA: XBRL DOCUMENT v3.21.1
Income taxes
12 Months Ended
Dec. 31, 2020
Income Taxes Tables [Abstract]  
15. Income taxes

15.

Income taxes

(a)

Provision for income taxes

The major components of provision for income taxes are as follows:

 

 

 

2020

 

 

2019

 

Current tax expense

 

 

 

 

 

 

Deferred tax expense

 

 

 

 

 

 

Provision for income taxes

 

 

 

 

 

 

 

The reconciliation of the provision for income taxes to the amount of income taxes calculated using statutory income tax rates applicable to the Company in Canada is as follows:

 

 

 

2020

 

 

2019

 

Canadian federal and provincial recovery of income taxes using statutory

   rate of 27% (2019 – 27%,)

 

 

(3,630

)

 

 

(2,653

)

Change in unrecognized deductible temporary differences and unused

   tax losses

 

 

3,093

 

 

 

4,534

 

Permanent differences and other

 

 

537

 

 

 

(1,881

)

Provision for income taxes

 

 

 

 

 

 

 

(b)

Deferred tax assets

As at December 31, the Company’s deferred tax assets are as follows:

 

 

 

2020

 

 

2019

 

Unused tax losses

 

 

222

 

 

 

37

 

 

(c)

Deferred tax liabilities

As at December 31, the Company’s deferred tax liabilities are as follows:

 

 

 

2020

 

 

2019

 

Convertible debentures

 

 

 

 

 

 

Deferred cost

 

 

222

 

 

 

37

 

 

 

 

222

 

 

 

37

 

 

(d)

Deductible temporary differences and unused tax losses

Deferred tax assets have not been recognized because it is not probable that future taxable profit will be available against which the Company can use the benefits therefrom.

15.

Income taxes (Continued from previous page)

As at December 31, the Company has deductible temporary differences for which no deferred tax assets are recognized as follows:

 

 

 

2020

 

 

2019

 

Property and equipment

 

 

2,946

 

 

 

2,103

 

Right-of-use assets, net lease liability

 

 

438

 

 

 

388

 

Intangible assets

 

 

10,346

 

 

 

3,205

 

Debentures

 

 

433

 

 

 

595

 

Convertible debentures

 

 

1,679

 

 

 

530

 

Financing costs

 

 

1,496

 

 

 

1,509

 

Research and development expenditures

 

 

1,437

 

 

 

1,437

 

Other

 

 

2,245

 

 

 

 

 

 

 

21,020

 

 

 

9,767

 

 

In addition to the deductible temporary differences listed above, as at December 31, the Company has unused tax losses for which no deferred tax assets are recognized as follows:

 

 

 

2020

 

 

2019

 

Expires 2024

 

 

610

 

 

 

610

 

Expires 2025

 

 

936

 

 

 

1,101

 

Expires 2026

 

 

2,112

 

 

 

2,136

 

Expires 2027

 

 

4,863

 

 

 

5,203

 

Expires 2028

 

 

2,064

 

 

 

2,064

 

Expires 2029

 

 

4,237

 

 

 

4,679

 

Expires 2030

 

 

3,698

 

 

 

3,698

 

Expires 2031

 

 

1,470

 

 

 

1,614

 

Expires 2032

 

 

3,772

 

 

 

4,854

 

Expires 2033

 

 

6,065

 

 

 

11,006

 

Expires 2034

 

 

7,416

 

 

 

8,420

 

Expires 2035

 

 

9,680

 

 

 

11,168

 

Expires 2036

 

 

18,713

 

 

 

18,886

 

Expires 2037

 

 

20,450

 

 

 

20,449

 

Expires 2038

 

 

20,214

 

 

 

20,214

 

Expires 2039

 

 

24,977

 

 

 

14,557

 

Expires 2040

 

 

169

 

 

 

 

 

 

 

131,446

 

 

 

130,659